Howerton Devery, Anderson Nancy, Bosse Diane, Granade Sharon, Westbrook Glennis
Division of Public Health Partnerships, National Center for Health Marketing, Coordinating Center for Health Information and Service, Atlanta, GA, 30341, USA.
MMWR Recomm Rep. 2005 Nov 11;54(RR-13):1-25; quiz CE1-4.
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), simple, low-risk tests can be waived and performed with no routine regulatory oversight in physicians' offices and various other locations. Since CLIA was implemented, waived testing has steadily increased in the United States. Surveys conducted during 1999-2004 by the Centers for Medicare & Medicaid Services and studies funded by CDC during 1999-2003 evaluated testing practices in sites holding a CLIA Certificate of Waiver (CW). Although study findings indicate CW sites generally take measures to perform testing correctly, they raise quality concerns about practices that could lead to errors in testing and poor patient outcomes. These issues are probably caused, in part, by high personnel turnover rates, lack of understanding about good laboratory practices, and inadequate training. This report summarizes study findings and provides recommendations developed by the Clinical Laboratory Improvement Advisory Committee for conducting quality waived testing. These recommendations include considerations before introducing waived testing, such as management responsibility for testing, regulatory requirements, safety, physical and environmental requirements, benefits and costs, staffing, and documentation. They also cover good laboratory practices for the three phases of testing: 1) before testing (test ordering and specimen collection), 2) during testing (control testing, test performance, and result interpretation and recording), and 3) after testing (result reporting, documentation, confirmatory testing, and biohazard waste disposal). They are intended to be used by those who would benefit from improving their knowledge of good laboratory practices. Continued monitoring of waived testing, with a focus on personnel education and training, is needed to improve practices and enhance patient safety as waived testing continues to increase.
根据1988年《临床实验室改进修正案》(CLIA),简单的低风险检测可以豁免,无需常规监管,可在医生办公室及其他场所进行。自CLIA实施以来,美国的豁免检测稳步增加。医疗保险和医疗补助服务中心在1999 - 2004年期间进行的调查以及疾病控制与预防中心在1999 - 2003年期间资助的研究评估了持有CLIA豁免证书(CW)的场所的检测实践。尽管研究结果表明CW场所通常会采取措施正确进行检测,但它们引发了对可能导致检测错误和患者不良后果的实践的质量担忧。这些问题可能部分是由高人员流动率、对良好实验室规范缺乏了解以及培训不足造成的。本报告总结了研究结果,并提供了临床实验室改进咨询委员会制定的关于进行高质量豁免检测的建议。这些建议包括在引入豁免检测之前的考虑因素,如检测的管理责任、监管要求、安全、物理和环境要求、收益和成本、人员配备以及文件记录。它们还涵盖了检测三个阶段的良好实验室规范:1)检测前(检测医嘱和样本采集),2)检测期间(对照检测、检测操作、结果解释和记录),以及3)检测后(结果报告、文件记录、确认检测和生物危害废物处理)。它们旨在供那些将从提高对良好实验室规范的认识中受益的人使用。随着豁免检测持续增加,需要持续监测豁免检测,重点是人员教育和培训,以改进实践并提高患者安全。